You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys S100 IVD Elecsys® S100 CPS_000510 08817324190 S100 Elecsys E2G 100 V2 Elecsys S100 07613336166161 Reagents, kits 100 tests cobas e 402/801 true 08817278190 S100 Elecsys cobas e 100 V2 Elecsys S100 07613336166154 Reagents, kits 100 tests cobas e 411/601/602 true 08817324500 Elecsys S100 en 5 FF0000000602E90E FF0000000436C70E 08817324190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of S100 (S100 A1B and S100 BB) in human serum. This assay can be usedto aid in the management of patients suffering from malignant melanoma (Elecsys S100 assay is not suitable for the diagnosis of malignant melanoma)to aid in the management of patients after potential brain injury in conjunction with clinical information and imaging techniquesThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08817278500 Elecsys S100 en 3 FF0000000603FE0E FF00000003B51B0E 08817278190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of S100 (S100 A1B and S100 BB) in human serum. This assay can be usedto aid in the management of patients suffering from malignant melanoma (Elecsys S100 assay is not suitable for the diagnosis of malignant melanoma)to aid in the management of patients after potential brain injury in conjunction with clinical information and imaging techniquesThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en
